AI assistant
Sending…
Alligator Bioscience — Major Shareholding Notification 2016
Nov 30, 2016
3138_iss_2016-11-30_df83e461-93d2-48df-b35a-f14d4bb7edf4.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer
Issuer Alligator Bioscience AB
Holder
Investor AB
Instrument
| Instrument | Shares SE0000767188 | |
|---|---|---|
| Before the transaction | ||
| Shares | Data not given* | |
| Voting rights | Data not given* | |
| Transaction | ||
| Reason for major shareholding notification Other | ||
| Date | 29/11/2016 | |
| Limit for number of shares | 5 % | |
| Limit for number of votes | 5 % | |
| After the transaction | ||
| Quantity | ||
| Shares | 4,614,636 | |
| Directly held voting rights | 0 | |
| Indirectly held voting rights | 4,614,636 | |
| Percentage | ||
| Directly held shares | 6.6 % | |
| Directly held voting rights | 0 % | |
| Indirectly held voting rights | 6.6 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 6.6 % | 4,614,636 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 |
1.3 % | 891,940 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
||
| - Physically settled | ||
| - Cash settled | ||
| Total | 7.9 % | 5,506,576 |
Chain of controlling companies
| Group total holdings | ||||
|---|---|---|---|---|
| 5,506,576 7.9 | Duba AB | |||
| Voting rights % Voting rights Company |
Voting rights 5,506,576 Percentage of voting rights 7.9
Notes (other relevant informations according to law)
Flaggningen avser ändrad sammansättning av Investors position, till följd av att aktier som utlånats för att underlätta s.k. settlement i börsnoteringserbjudandet avseende Alligator har återfåtts.
Published
30/11/2016 14:14
Contact
Name Petra Hedengren
Phone 004686142000 Email [email protected]
*Source of information has chosen not to submit the data
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Alligator Bioscience
AGM Information
2026
May 6
AGM Information
2026
May 6
Interim / Quarterly Report
2026
May 5
Interim / Quarterly Report
2026
May 5
Share Issue/Capital Change
2026
Mar 31
Share Issue/Capital Change
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Board/Management Information
2026
Mar 27
Board/Management Information
2026
Mar 27